文献速递肿瘤 PET/CT骨显像与常规 SPECT

基线FDG PET/CT自动计算Deauville评分预测多发性骨髓瘤无进展生存:一项放射基因组学框架

Automated Deauville Score computation from baseline [¹⁸F]FDG PET/CT predicts progression-free survival in multiple myeloma: a radiogenomic framework.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-07-30

该回顾性研究纳入165例新诊断多发性骨髓瘤患者,开发自动化流程计算基线[18F]FDG PET/CT的Deauville评分(DS),并整合拷贝数变异(CNA)与临床变量预测无进展生存(PFS)。惩罚Cox模型预测进展风险的C-index为0.710(95%CI 0.689-0.732),年龄、血红蛋白、BM DS、PM DS和amp(1q)为独立预后因素。自动化DS计算可行,结合基因组与临床数据可实现可重复的多模态预后分层。

要点

  • 高LB、PM和EM DS与更短PFS显著相关。
  • 惩罚Cox模型预测进展风险的C-index为0.710(95%CI 0.689-0.732)。
  • 年龄、血红蛋白、BM DS、PM DS和amp(1q)为独立预后因素。

核心结论

  • 基线FDG PET/CT自动计算DS可行,结合基因组和临床数据可实现可重复的多模态预后分层。

研究设计与样本

  • 回顾性队列纳入165例新诊断多发性骨髓瘤患者,具备基线FDG PET/CT、CNA分析和血液检查。
  • 自动化流程全自动计算椎体骨髓(BM)和长骨(LB)的DS,半自动计算局灶(FL)、椎旁(PM)和髓外(EM)病变的DS。
  • DS分为缺失(1)、低(2-3)和高(4-5)组,采用log-rank检验比较。
  • 采用嵌套交叉验证评估含12个协变量的惩罚Cox模型预测PFS。
  • 在全队列上拟合非惩罚多变量Cox模型进行个体预后贡献推断。

主要发现

  • 单变量分析中,高LB、PM和EM DS与更短PFS显著相关。
  • 惩罚Cox模型预测进展风险的C-index为0.710(95%CI 0.689-0.732)。
  • 多变量分析中,年龄、血红蛋白、BM DS、PM DS和amp(1q)被确定为独立预后因素。

关键数值与推荐

  • DS分组:缺失(1)、低(2-3)、高(4-5)。
  • 惩罚Cox模型纳入12个协变量:五个DS、三个CNA、血红蛋白、血小板计数、年龄、性别。
  • 预测进展风险的C-index为0.710(95%CI 0.689-0.732)。

临床怎么用

  • 自动化DS计算流程(autoDS-PET)已作为开源工具公开,可用于标准化DS评估。
  • 结合DS、CNA和临床变量可对多发性骨髓瘤患者进行预后分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Deauville Score (DS) assessment from [18F]FDG PET/CT in multiple myeloma (MM) relies on visual interpretation, limiting reproducibility. This study aimed to develop an automated pipeline for standardised DS computation, evaluate the prognostic value of DS at five anatomical sites, and predict progression-free survival (PFS) by integrating DS with copy number alterations (CNA) and clinical variables. METHODS: A retrospective cohort of 165 newly diagnosed MM patients with baseline FDG PET/CT, CNA profiling, and blood tests was analysed. An automated pipeline computed DS fully automatically for vertebral bone marrow (BM) and long bones (LB), and semi-automatically for focal (FL), paramedullary (PM), and extramedullary (EM) lesions. DS were subdivided into absent (1), low (2-3), and high (4-5) groups and compared via log-rank test. A penalised Cox model with 12 covariates (five DS, three CNAs, haemoglobin, platelet count, age, sex) was evaluated via nested cross-validation for PFS prediction. For inference on individual prognostic contributions, an unpenalised multivariable Cox model was fitted on the full cohort. RESULTS: In univariate analyses, high LB, PM and EM DS were significantly associated with shorter PFS. The penalised Cox model achieved a C-index of 0.710 [95% CI: 0.689-0.732] in predicting the risk of progression. In the multivariable analysis, age, haemoglobin, BM DS, PM DS and amp(1q) were identified as independent prognostic factors. CONCLUSION: Automated DS computation from baseline FDG PET/CT is feasible and, combined with genomic and clinical data, enables a reproducible multimodal approach to prognostic stratification in MM. The pipeline for DS computation is publicly available as an open-source tool (autoDS-PET) at https://github.com/Sara-Peluso/autoDS-PET .

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Peluso S, Polizzi S, Pagnini L, et al. Automated Deauville Score computation from baseline [¹⁸F]FDG PET/CT predicts progression-free survival in multiple myeloma: a radiogenomic framework. Eur J Nucl Med Mol Imaging. 2026. PMID: 42530578. doi:10.1007/s00259-026-08103-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。